Niosomal delivery of Celecoxib and Metformin for targeted breast cancer treatment
HA Basheer, MA Alhusban, A Zaid Alkilani… - Cancers, 2023 - mdpi.com
… This study investigates the therapeutic efficacy of combining Metformin (MET) and Celecoxib
(… We conducted an optimization process to ascertain the duration required for the complete …
(… We conducted an optimization process to ascertain the duration required for the complete …
Novel celecoxib-loaded chitosan-fucoidan nanoparticles as potential immunotherapy for oral squamous cell carcinoma: Mechanistic insights
AA Mabrouk, NS El-Mezayen, AK Awaad… - Journal of Drug Delivery …, 2023 - Elsevier
… Progress in molecular biology revealed the … at combining two active compounds in formulating
CXB-loaded CS/FCD NPs, tumor cell lines can be used to determine the best combination …
CXB-loaded CS/FCD NPs, tumor cell lines can be used to determine the best combination …
A curve-free Bayesian decision-theoretic design for phase Ia/Ib trials considering both safety and efficacy outcomes
… a new drug or drug combination to humans, a phase I oncology trial traditionally focuses on
… The BOD was determined at the lowest dose level (of celecoxib) showing optimal biological …
… The BOD was determined at the lowest dose level (of celecoxib) showing optimal biological …
Updated perspectives on the diagnosis and management of familial adenomatous polyposis
F Kyriakidis, D Kogias, TM Venou… - The Application of …, 2023 - Taylor & Francis
… The ideal chemoprevention agent should demonstrate a biologically plausible mechanism
of … When the combination between celecoxib and DFMO was tested in a randomised clinical …
of … When the combination between celecoxib and DFMO was tested in a randomised clinical …
… cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial
… In a previous phase 2 study, patients with head and neck cancer … We aimed to do a phase
3 study to substantiate these … combination of weekly methotrexate plus daily celecoxib should …
3 study to substantiate these … combination of weekly methotrexate plus daily celecoxib should …
Development and characterization of celecoxib solid self-nanoemulsifying drug delivery systems (S-SNEDDS) prepared using novel cellulose-based microparticles as …
FP Schmied, A Bernhardt, V Baudron, B Beine… - AAPS …, 2022 - Springer
… excipient combination for a given drug has been determined, … different chemical as well as
biological origins can be utilized … The best-performing excipient composition and mixing ratio …
biological origins can be utilized … The best-performing excipient composition and mixing ratio …
Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials
A Neiheisel, M Kaur, N Ma, P Havard… - … Journal of Cancer, 2022 - Wiley Online Library
… The Wnt signaling is an evolutionarily conserved biological … Phase Ib trial is currently
underway involving a combination … , a Phase II clinical trial in CRC patients treated with celecoxib …
underway involving a combination … , a Phase II clinical trial in CRC patients treated with celecoxib …
Phase I trial combining chemokine-targeting with loco-regional chemoimmunotherapy for recurrent, platinum-sensitive ovarian cancer shows induction of CXCR3 …
… We performed a first-in-human, phase 1 dose-escalation clinical trial of intraperitoneal
cisplatin plus local rintatolimod/IFNα/celecoxib, the CKM combination synergistically promoting …
cisplatin plus local rintatolimod/IFNα/celecoxib, the CKM combination synergistically promoting …
Metronomic therapy in oral squamous cell carcinoma
NW Su, YJ Chen - Journal of Clinical Medicine, 2021 - mdpi.com
… and celecoxib (200 mg twice daily). In phase I, they first determined the optimal biological
dose … immune checkpoint inhibitor and metronomic chemotherapy combination in lung cancer (…
dose … immune checkpoint inhibitor and metronomic chemotherapy combination in lung cancer (…
Formulation of gelled microemulsion for effective permeation of celecoxib across the skin barrier
MY Siddique, MF Nazar, MA Saleem, S Haider… - …, 2024 - Wiley Online Library
… The surfactant/cosurfactant mixture (S mix ) (9 : 1) was mixed with oil … (800 rpm; 2 hour) to
determine the optimal concentration. … changes in w/o to o/w were observed under the biological …
determine the optimal concentration. … changes in w/o to o/w were observed under the biological …